NEW ALZHEIMER’S WONDER DRUG: ARE YOU ELIGIBLE?

Nearly 13 million people will have Alzheimer's disease by 2050. A new FDA approved drug called Leqembi, has been shown to slow dementia. So why won’t Medicare cover it? Dr. Nicole Purcell, neurologist and senior director of clinical practice for the Alzheimer's Association joins us.